Lipoprotein-X fifty years after its original discovery-Reference-Cited by-同舟云学术

Lipoprotein-X fifty years after its original discovery

Published:2019-01 Issue:1 Volume:29 Page:4-8
ISSN:0939-4753
Container-title:Nutrition, Metabolism and Cardiovascular Diseases
language:en
Short-container-title:Nutrition, Metabolism and Cardiovascular Diseases

Author:

Fellin R.,Manzato E.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Reference44 articles.

1. Bile acid metabolism and signaling in cholestasis, inflammation, and cancer;Li;Adv Pharmacol,2015

2. Suppression of bile acid synthesis, but not of hepatic cholesterol 7-hydroxylase expression, by obstructive cholestasis in humans;Bertolotti;Hepatology,2001

3. Serum 27-hydroxycholesterol in patients with primary biliary cirrhosis suggests alteration of cholesterol catabolism to bile acids via the acidic pathway;Del Puppo;J Lipid Res,1998

4. High Expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis;Schaap;Hepatology,2009

5. Expression of hepatic fibroblast growth factor 19 is enhanced in primary biliary cirrhosis and correlates with severity of the disease;Wunsch;Sci Rep,2015

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unresolved alterations in bile acid composition and dyslipidemia in maternal and cord blood after ursodeoxycholic acid treatment for intrahepatic cholestasis of pregnancy;2024-08-21

2. Systemic Complications of Primary Biliary Cholangitis;Clinics in Liver Disease;2024-02

3. Lipoprotein X in the Setting of COVID-19–Induced Cholangiopathy: An Unforeseen Event;Annals of Internal Medicine: Clinical Cases;2024-01-01

4. The necessity for improving lipid testing reagents: A real world study;Clinica Chimica Acta;2023-08

5. Dyslipidemia and its features in primary biliary cholangitis;Health care of Tajikistan;2023-03-30